Duan Qiangde, Lu Ti, Garcia Carolina, Yañez Coraima, Nandre Rahul M, Sack David A, Zhang Weiping
Department of Diagnostic Medicine, Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, KS, United States.
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Front Microbiol. 2018 Jun 5;9:1198. doi: 10.3389/fmicb.2018.01198. eCollection 2018.
Enterotoxigenic (ETEC) bacteria remain a leading cause of children's diarrhea and travelers' diarrhea. Vaccines that induce antibodies to block ETEC bacterial adherence and to neutralize toxin enterotoxicity can be effective against ETEC-associated diarrhea. Recent studies showed that 6xHis-tagged CFA/I/II/IV multiepitope fusion antigen (MEFA) induced broad-spectrum antibodies to inhibit adherence of the seven most important ETEC adhesins (CFA/I, CS1 to CS6) (Ruan et al., 2014a) and 6xHis-tagged toxoid fusion antigen 3xSTa-mnLT (previously named as 3xSTa-dmLT) elicited antibodies to neutralize both heat-labile toxin (LT) and heat-stable toxin (STa) produced by ETEC strains (Ruan et al., 2014b). In this study, we constructed two new genes to express tag-less toxoid fusion 3xSTa-mnLT and tag-less CFA/I/II/IV MEFA and then examined immunogenicity of each tag-less protein in mouse immunization. We further combined two tag-less proteins and investigated antigen co-administration in mice. Data showed that mice immunized with tag-less 3xSTa-mnLT or tag-less CFA/I/II/IV MEFA developed antigen-specific IgG antibody responses, and mice co-administered with two tag-less proteins induced neutralizing antibodies against seven adhesins and both toxins. These results indicated tag-less toxoid fusion 3xSTa-mnLT and tag-less CFA/I/II/IV MEFA administered individually or combined induced neutralizing antitoxin and/or anti-adhesin antibodies, and suggested the potential application of two tag-less proteins for ETEC vaccine development.
产肠毒素大肠杆菌(ETEC)仍是儿童腹泻和旅行者腹泻的主要病因。诱导抗体以阻断ETEC细菌黏附并中和毒素肠毒性的疫苗可有效预防与ETEC相关的腹泻。最近的研究表明,6xHis标记的CFA/I/II/IV多表位融合抗原(MEFA)可诱导产生广谱抗体,抑制七种最重要的ETEC黏附素(CFA/I、CS1至CS6)的黏附(阮等人,2014年a),且6xHis标记的类毒素融合抗原3xSTa-mnLT(先前称为3xSTa-dmLT)可引发抗体,中和ETEC菌株产生的不耐热毒素(LT)和耐热毒素(STa)(阮等人,2014年b)。在本研究中,我们构建了两个新基因,以表达无标签的类毒素融合3xSTa-mnLT和无标签的CFA/I/II/IV MEFA,然后在小鼠免疫中检测每种无标签蛋白的免疫原性。我们进一步将两种无标签蛋白组合,并研究了在小鼠中的抗原共同给药情况。数据显示,用无标签的3xSTa-mnLT或无标签的CFA/I/II/IV MEFA免疫的小鼠产生了抗原特异性IgG抗体反应,同时给予两种无标签蛋白的小鼠诱导产生了针对七种黏附素和两种毒素的中和抗体。这些结果表明,单独或联合给予无标签的类毒素融合3xSTa-mnLT和无标签的CFA/I/II/IV MEFA可诱导产生中和抗毒素和/或抗黏附素抗体,并提示这两种无标签蛋白在ETEC疫苗开发中的潜在应用价值。